Genmab — April 2016
-
plus 19.7, der er tale om increased sales
-
præsentationen er ved at winde ned nu - mon ikke Q&A har noget interessant?
-
JPM - darzalex: uptake in MM, how do you see playing out?
-
cfo og ir chef vil ikke give yderligere. nævner 2% vækst contribution i US og castor blevet stoppet
-
der kommer nok ikke yderligere kød på det ben
-
men interessant, at det er JPM, der spørger ind til dara. Jeg har ikke noteret noget kurstarget på GEN fra deres side. Er der nogen, der har noget der?
-
well - det ligner nu mere at svenskerne sælger i panik
-
GS spørger i øvrigt ind til JJs balance - analytikeren kan ikke rigtig forstå niveauet af cash på balancen...
-
"while we are evaluating m&a opportunities..." siger cfo
-
men han er sgu en glat ål
-
"we are all surprised you haven't done more with the balance sheet"
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind